Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment
Abstract Background Clear-cell renal cell carcinomas (ccRCCs) are malignant tumors with high metastatic potential and resistance to treatments occurs almost constantly. Compared to primary tumors, there are still limited genomic data that has been obtained from metastatic samples. Methods We aimed t...
Main Authors: | Thi Oanh Bui, Eurydice Angeli, Morad El Bouchtaoui, Guillaume Gapihan, Van Tu Dao, Justine Paris, Christophe Leboeuf, Michael Soussan, Patrick Villarese, Marianne Ziol, Emmanuel Van Glabeke, Thi Huong Le, Jean-Paul Feugeas, Anne Janin, Guilhem Bousquet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Experimental Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40164-023-00408-z |
Similar Items
-
The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer
by: Michele Vigolo, et al.
Published: (2023-08-01) -
Role of Notch Receptors in Hematologic Malignancies
by: Laura Gragnani, et al.
Published: (2020-12-01) -
A brief overview of clinical significance of novel Notch2 regulators
by: Joanna Pancewicz
Published: (2020-09-01) -
Enhanced Delta-Notch lateral inhibition model incorporating intracellular notch heterogeneity and tension-dependent rate of Delta-Notch binding that reproduces sprouting angiogenesis patterns
by: Koon, Yen Ling, et al.
Published: (2018) -
A study to investigate the anticancer potential of carvacrol via targeting Notch signaling in breast cancer
by: Pandey Pratibha, et al.
Published: (2024-04-01)